Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
That small change might make all the difference in keeping your weight loss journey smooth and sustainable
This slow ramp-up minimizes gastrointestinal side effects but means that the full weight loss effect does not kick in immediately
Semaglutide was originally developed to help people with type 2 diabetes manage their blood sugar levels
Recording these symptoms helps you identify patterns or triggers, such as certain foods or times of day when side effects are more pronounced
Research Rationale Retatrutide addresses systemic energy homeostasis through incretin and glucagon receptor signalling MOTS-C targets cellular energy sensing via AMPK and mitochondrial regulation Triple agonism (GLP-1 + GIP + glucagon) provides broader receptor coverage than single or dual agonists, while MOTS-C adds a mitochondrial dimension not addressed by incretin-based compounds Retatrutide modulates insulin and glucagon secretion in glucose-dependent in vitro models MOTS-C enhances glucose uptake and fatty acid oxidation in cultured myocytes and hepatocytes Each peptide is individually vialled with independent batch COAs titrate each separately in your assay design Research Applications Commonly employed in metabolic disease research using beta-cell lines (MIN6, INS-1), primary hepatocyte cultures, and 3T3-L1 adipocyte differentiation models
US$ 28.45
US$ 28.26
US$ 24.52
